Catalent Publishes Fifth Annual Corporate Responsibility Report, Demonstrating Commitment to Sustainability and Social Impact

    One of the notable achievements in fiscal 2023 was Catalent's robust efforts to mitigate its environmental impact and combat climate ...

March 08, 2024 | Friday | News
Exscientia Dismisses CEO Andrew Hopkins Over Inappropriate Relationships

Exscientia plc (Nasdaq: EXAI), a frontrunner in AI-driven precision medicine, has officially announced a significant leadership adjustment and the submissi...

February 14, 2024 | Wednesday | News
Catalent's Meteoric Rise as Novo Holdings Makes Groundbreaking Acquisition

In a landmark move within the life sciences sector, Novo Holdings has announced its acquisition of Catalent, Inc. in an all-cash transaction valued at $16....

February 08, 2024 | Thursday | News
Biotage AB Initiates Leadership Transition for Next Growth Phase

  From The BioPharma BoardRoom Lens   The news of Tomas Blomquist stepping down from his role as CEO & President of Biotage AB carries sev...

January 09, 2024 | Tuesday | Analysis
Element Biosciences Unleashes Next-Level Genomics Innovation: CEO Molly He Unveils AVITI Advancements at #JPM2024

The company is set to introduce multi-omics capabilities on the AVITI platform, along with enhancements to the first commercial Q50 kit and a host of workf...

January 09, 2024 | Tuesday | News
QIAGEN Unleashes a Thrilling Windfall: Proposes a Whopping $300 Million Bonanza for Shareholders!

QIAGEN  announced a plan to return up to approximately $300 million (maximum EUR 273 million) to shareholders through a synthetic share repurchase tha...

January 08, 2024 | Monday | News
Sutro Biopharma Spotlights Luvelta's Multi-Cancer Potential as FolRα ADC

Ovarian cancer data supports registration-enabling trial of luvelta for women with platinum-resistant ovarian cancer Potential benefit to 8 out of 10 plat...

January 05, 2024 | Friday | News
Setting Sail in 2024: BioPharma Boardroom's Strategic Compass

As we stand on the precipice of 2024, the life sciences industry continues its dynamic evolution, propelled by groundbreaking discoveries, technological ad...

January 01, 2024 | Monday | News
OmniAb Unveils Latest Scientific Data on OmnidAb™ Platform at 2023 Antibody Engineering Conference

OmniAb, Inc.  announces the presentation of new scientific data on its OmnidAb™ platform, the industry’s first and only transgenic chicken...

December 15, 2023 | Friday | News
Singapore's Engine Biosciences Secures $27M in Series A Extension for Precision Oncology Development and Biomarker Research

Funds to support translation of R&D programs derived from proprietary NetMAPPR machine learning network biology platform and CombiGEM combinatorial gen...

November 02, 2023 | Thursday | News
Government of Serbia and Ginkgo Bioworks Announce Bioeconomy Collaboration in BIO4 Campus

Under the planned partnership, Ginkgo and the Serbian Ministry of Science, Technological Development and Innovation will work to establish a Startup Accele...

October 23, 2023 | Monday | News
Indivior Enters an Exclusive Licensing Agreement with Alar Pharmaceuticals

Indivior PLC (LSE/Nasdaq: INDV), a leading addiction treatment company, today announced that it has gained exclusive global rights to develop, manufacture,...

October 12, 2023 | Thursday | News
Bayer to present latest real-world evidence of menopausal symptoms and their treatment

Real-world evidence (RWE) research results on treatment utilization and pathways in women with menopausal symptoms via poster presentations on the CHAPTE...

September 28, 2023 | Thursday | News
Longeveron Exceeds 50% Enrollment in Lomecel-B™ Study for Hypoplastic Left Heart Syndrome

Company Activates Additional Study Location to Expedite Enrollment Completion HLHS is a congenital birth defect in which the left ventricle (one of the pu...

August 14, 2023 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.


Forgot your password?



Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in